Pharmaceutical companies are responsible when it comes to tracking and managing alerts on their products. A suitable tool for this has not yet been available. EMVO is now reacting, but it will take time until the AMS project is completed. Throughout Europe, only a few counterfeit drugs have been found by the serialization system so […]
Hospital pharmacies are frequented quite differently from public pharmacies. In hospital pharmacies, large quantities of Rx drugs are delivered and distributed every day. This includes most of the drugs that are needed in daily hospital life. In connection with the requirements of the European Counterfeiting Directive (EU-FMD), this means that a large number of drugs […]
Exactly one year ago to the day the anti-counterfeiting systems went live in Europe. We look back on the eventful and successful year 2019. Since February 2019, more than one billion drug packages have been given a unique digital identity – in Germany alone. More than six million scans are performed in pharmacies every day. […]
Read More… from One Year of Europe-wide Counterfeit Protection
In the pharmaceutical industry, Digital Twins are being used to combat product counterfeiting. They not only offer added value for the industry but also ensure greater patient safety. In this white paper we answer the questions about how exactly Digital Twins are used in the pharmaceutical industry and what we have learned from the implementation […]
Read More… from Whitepaper: Digital Twins in the Pharmaceutical Industry
Analyzing, automating, data integrity, patient centricity, data mining, process optimization – Pharma 4.0 is versatile. But what is meant by this and why does digitalization still have room for improvement in the pharmaceutical industry? Pharma 4.0 is part of the Internet of Things (IoT). The term describes the part of the IoT that affects the […]
Read More… from After Serialization: What Does Pharma 4.0 Mean?
Russia has been serializing since July 2020. The marking of Rx and OTC drugs with crypto codes is part of a large-scale track-and-trace project. It is intended to make an important contribution to greater patient and consumer safety in Russia. In addition to the safety aspect, however, economic interests are also in the foreground. Counterfeit […]
Read More… from Serialization in Russia: Crypto Codes As a Security Measure
Pharmaceutical companies specializing in the production of over-the-counter drugs (OTC) have not been affected by pharmaceutical serialization so far. This is now changing for companies that are also active on the Russian market. The serialization requirements in Russia are much more complex than those of the EU-FMD. The so-called EU Counterfeiting Directive has been in […]
An editorial by Daniel Althoff, Product Manager From now on, the tracekey “perspective” series contains texts by our employees on important topics in the industry. Daniel Althoff gives his opinion on the much-discussed Blockchain. >>When I first had to deal with the term “blockchain” professionally, I sat in a meeting with consultants and anti-counterfeiting experts. […]
The implementation of EU-FMD is not the only track&trace initiative to protect against counterfeit medicines. Many projects around the world are more or less based on similar standards but are all aimed at protecting patients and making supply chains counterfeit-proof. I.e. Russian Crypto-Codes and the serialization requirements in China. Russia and China are two countries […]
Read More… from Crypto-Code and language barriers: Serialization in Russia and China
Blockchain is to be used in the healthcare industry. The Federal Ministry of Health has launched a competition to find projects that will reduce the number of counterfeit prescriptions. The competition entries show that blockchain can be used in many ways in the healthcare sector. In the competition ideas and solutions were searched, which are […]
Read More… from Blockchain: The future for healthcare in Germany?